United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.
30 August 2018 - 1:08PM
PR Newswire (US)
SILVER SPRING, Md.,
Aug. 30, 2018 /PRNewswire/
-- United Therapeutics Corporation (NASDAQ: UTHR) ("United
Therapeutics") today announced that it has closed the merger of
SteadyMed Ltd. (NASDAQ: STDY) ("SteadyMed") with a subsidiary of
United Therapeutics. Pursuant to the merger, United Therapeutics
acquired all of the outstanding ordinary shares of SteadyMed. As a
result of the merger, SteadyMed ordinary shares are no longer
publicly traded on the NASDAQ Stock Market.
About United Therapeutics
United Therapeutics is a biotechnology company focused on the
development and commercialization of innovative products to address
the unmet medical needs of patients with chronic and
life-threatening conditions. [uthr-g]
View original
content:http://www.prnewswire.com/news-releases/united-therapeutics-corporation-completes-acquisition-of-steadymed-ltd-300704754.html
SOURCE United Therapeutics Corporation
Copyright 2018 PR Newswire
STEADYMED LTD. (NASDAQ:STDY)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
STEADYMED LTD. (NASDAQ:STDY)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Steadymed Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 Nachrichtenartikel
Weitere SteadyMed Ltd. News-Artikel